New muscle relaxant HRS-9190 tested in surgery trial

NCT ID NCT07404579

Completed Disease control Sponsor: Jiangsu HengRui Medicine Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new drug called HRS-9190 against a standard muscle relaxant (rocuronium) in 103 adults having surgery. The goal was to see how quickly muscles recover after the last dose. Researchers also checked for side effects. The drug is meant to keep muscles relaxed during anesthesia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HRS-9190 (a muscle relaxant drug)
What this could lead to: If successful, this could provide a new option for muscle relaxation during surgery, potentially with a better safety or recovery profile than current drugs.
What could go wrong: This is an early phase 2 trial with only 103 participants, so results may not apply to everyone. The drug may not work better or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROMUSCULAR BLOCKADE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROMUSCULAR BLOCKADE

Contacts and locations

Locations

Henan Provincial People's Hospital

Zhengzhou, Henan, 450004, China
Shanghai Jiaotong University School of Medicine, Renji Hospital

Shanghai, Shanghai Municipality, 200000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.